IL158534A0 - Oligonucletide compositions and their use to induce differentation of cells - Google Patents
Oligonucletide compositions and their use to induce differentation of cellsInfo
- Publication number
- IL158534A0 IL158534A0 IL15853402A IL15853402A IL158534A0 IL 158534 A0 IL158534 A0 IL 158534A0 IL 15853402 A IL15853402 A IL 15853402A IL 15853402 A IL15853402 A IL 15853402A IL 158534 A0 IL158534 A0 IL 158534A0
- Authority
- IL
- Israel
- Prior art keywords
- cells
- compositions
- seq
- differentiation
- induce
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/117—Nucleic acids having immunomodulatory properties, e.g. containing CpG-motifs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
- A61K31/7105—Natural ribonucleic acids, i.e. containing only riboses attached to adenine, guanine, cytosine or uracil and having 3'-5' phosphodiester links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/18—Type of nucleic acid acting by a non-sequence specific mechanism
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biochemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Diabetes (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US28615801P | 2001-04-24 | 2001-04-24 | |
US10/127,645 US7087586B2 (en) | 2001-04-24 | 2002-04-22 | Oligonucleotide compositions and their use to induce differentiation of cells |
PCT/CA2002/000573 WO2002085340A2 (en) | 2001-04-24 | 2002-04-23 | Oligonucleotide compositions and their use to induce differentiation of cells |
Publications (1)
Publication Number | Publication Date |
---|---|
IL158534A0 true IL158534A0 (en) | 2004-05-12 |
Family
ID=26825829
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL15853402A IL158534A0 (en) | 2001-04-24 | 2002-04-23 | Oligonucletide compositions and their use to induce differentation of cells |
IL158534A IL158534A (en) | 2001-04-24 | 2003-10-21 | Oligonucleotide compositions and their use to induce cell differentiation |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL158534A IL158534A (en) | 2001-04-24 | 2003-10-21 | Oligonucleotide compositions and their use to induce cell differentiation |
Country Status (12)
Country | Link |
---|---|
US (2) | US7087586B2 (xx) |
EP (1) | EP1381375B1 (xx) |
JP (1) | JP4460220B2 (xx) |
KR (1) | KR100913860B1 (xx) |
AT (1) | ATE489467T1 (xx) |
AU (1) | AU2002252891B2 (xx) |
CA (1) | CA2445071A1 (xx) |
DE (1) | DE60238393D1 (xx) |
IL (2) | IL158534A0 (xx) |
MX (1) | MXPA03009761A (xx) |
NZ (1) | NZ529160A (xx) |
WO (1) | WO2002085340A2 (xx) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100971571B1 (ko) * | 2001-10-03 | 2010-07-20 | 바이오니취 라이프 사이언시즈 인코포레이티드 | 치료적으로 유용한 트리에틸렌글리콜 콜레스테릴올리고뉴클레오타이드 |
EP1497424A1 (en) * | 2002-04-22 | 2005-01-19 | Bioniche Life Sciences Inc. | Oligonucleotide compositions and their use for the modulation of immune responses |
US20050101576A1 (en) * | 2003-11-06 | 2005-05-12 | Novacea, Inc. | Methods of using vitamin D compounds in the treatment of myelodysplastic syndromes |
WO2007028985A2 (en) * | 2005-09-07 | 2007-03-15 | The Secretary Of State For Defence | Adjuvanted vaccine |
WO2009143292A2 (en) * | 2008-05-21 | 2009-11-26 | The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Method of treating pneumoconiosis with oligodeoxynucleotides |
US8053422B2 (en) | 2008-12-04 | 2011-11-08 | The United States Of America As Represented By The Department Of Health And Human Services | Anti-cancer oligodeoxynucleotides |
GB0906234D0 (en) | 2009-04-14 | 2009-05-20 | Secr Defence | Vaccine |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5567604A (en) * | 1993-04-23 | 1996-10-22 | Aronex Pharmaceuticals, Inc. | Anti-viral guanosine-rich oligonucleotides |
US5866332A (en) * | 1994-02-02 | 1999-02-02 | Incyte Pharmaceuticals, Inc. | Human myeloid terminal differentiation response gene |
US5994320A (en) * | 1995-02-06 | 1999-11-30 | Regents Of The University Of Minnesota | Antisense oligonucleotides and methods for treating central nervous system tumors |
US5851984A (en) * | 1996-08-16 | 1998-12-22 | Genentech, Inc. | Method of enhancing proliferation or differentiation of hematopoietic stem cells using Wnt polypeptides |
WO1999058118A2 (en) * | 1998-05-14 | 1999-11-18 | Cpg Immunopharmaceuticals Gmbh | METHODS FOR REGULATING HEMATOPOIESIS USING CpG-OLIGONUCLEOTIDES |
WO2001044465A2 (en) * | 1999-12-13 | 2001-06-21 | Bioniche Life Sciences Inc. | Therapeutically useful synthetic oligonucleotides |
US20020091095A1 (en) * | 1999-12-13 | 2002-07-11 | Phillips Nigel C. | Modulation of Fas and FasL expression |
JP4215429B2 (ja) | 1999-12-28 | 2009-01-28 | バイオニケ ライフ サイエンシーズ インコーポレイテッド | 癌治療におけるヒアルロン酸 |
MXPA03001812A (es) * | 2000-08-29 | 2004-05-21 | Bioniche Life Sciences Inc | Modulacion de la expresion del sindrome de alcohol fetal y del ligando del sindrome de alcohol fetal.. |
MXPA04001480A (es) * | 2001-08-17 | 2004-05-20 | Bioniche Life Sciences Inc | Composiciones de oligonucleotido y su uso para inducir apoptosis. |
-
2002
- 2002-04-22 US US10/127,645 patent/US7087586B2/en not_active Expired - Fee Related
- 2002-04-23 NZ NZ529160A patent/NZ529160A/en not_active IP Right Cessation
- 2002-04-23 CA CA002445071A patent/CA2445071A1/en not_active Abandoned
- 2002-04-23 JP JP2002582914A patent/JP4460220B2/ja not_active Expired - Fee Related
- 2002-04-23 EP EP02721915A patent/EP1381375B1/en not_active Expired - Lifetime
- 2002-04-23 AU AU2002252891A patent/AU2002252891B2/en not_active Ceased
- 2002-04-23 WO PCT/CA2002/000573 patent/WO2002085340A2/en active Application Filing
- 2002-04-23 MX MXPA03009761A patent/MXPA03009761A/es active IP Right Grant
- 2002-04-23 IL IL15853402A patent/IL158534A0/xx unknown
- 2002-04-23 DE DE60238393T patent/DE60238393D1/de not_active Expired - Lifetime
- 2002-04-23 KR KR1020037013799A patent/KR100913860B1/ko not_active IP Right Cessation
- 2002-04-23 AT AT02721915T patent/ATE489467T1/de not_active IP Right Cessation
-
2003
- 2003-10-21 IL IL158534A patent/IL158534A/en not_active IP Right Cessation
-
2006
- 2006-06-08 US US11/449,152 patent/US20070010472A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
JP4460220B2 (ja) | 2010-05-12 |
US20070010472A1 (en) | 2007-01-11 |
ATE489467T1 (de) | 2010-12-15 |
CA2445071A1 (en) | 2002-10-31 |
KR100913860B1 (ko) | 2009-08-26 |
AU2002252891B2 (en) | 2007-09-20 |
JP2004526775A (ja) | 2004-09-02 |
WO2002085340A2 (en) | 2002-10-31 |
EP1381375B1 (en) | 2010-11-24 |
NZ529160A (en) | 2006-06-30 |
KR20040047749A (ko) | 2004-06-05 |
MXPA03009761A (es) | 2004-01-29 |
US7087586B2 (en) | 2006-08-08 |
US20030045493A1 (en) | 2003-03-06 |
WO2002085340A3 (en) | 2003-10-30 |
EP1381375A2 (en) | 2004-01-21 |
DE60238393D1 (de) | 2011-01-05 |
IL158534A (en) | 2010-06-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2186525A3 (en) | G-CSF for use in the treatment of Parkinson's disease | |
ATE300613T1 (de) | Menschliche, für zyklische nukleotide spezifische phosphodiesterase | |
ES2375058T8 (es) | Axmi-010, un gen de la delta-endotoxina y métodos para su uso. | |
WO2002102997A3 (en) | Isolated homozygous stem cells differentiated cells derived therefrom and materials and methods for making and using same | |
EP1947184A3 (en) | Delta-endotoxin genes and methods for their use | |
EP1778842B8 (en) | Compositions and methods of use for mgd-csf in disease treatment | |
NZ331815A (en) | A method for preparing cell lines that have artificial chromosomes, uses thereof and methods for preparing artificial chromosomes in particular they are satellite artificial chromosomes that are composed of heterochromatin and the inserted heterologous DNA | |
RU2006135131A (ru) | Улучшенные мутеины интерлейкина-2 | |
SG127738A1 (en) | Heterocyclic compounds based on n6-substituted adenine, methods of their preparation, their use for preparation of drugs, pharmaceutical preparations containing these compounds | |
BR9206027A (pt) | Análogo de oligonucleotídio, composto de subunidade de oligonucleotídeo, processo para preparar tal composto, processo para modular a produção ou atividade de uma proteína, e, processo para tratar um organismo tendo uma doença distinta pela produção indesejada de uma proteína | |
WO2005021585A3 (en) | Axmi-003, a delta-endotoxin gene and methods for its use | |
AU9084601A (en) | G-csf analog compositions and methods | |
BG102973A (en) | LIGAND RET (RetL) FOR THE STIMULATION OF THE NERVE AND RENAL GROWTH | |
IL176268A0 (en) | Use of alginate matrices to control cell growth | |
IL158534A0 (en) | Oligonucletide compositions and their use to induce differentation of cells | |
JPS6423858A (en) | Animal feed additive, feed containing the same and animal growth improving method | |
ATE190352T1 (de) | Dorsalgewebe beeinflussender faktor und zusammensetzungen | |
CY1106041T1 (el) | Καινοφανης συλλεκτινη | |
ES2173856T3 (es) | Proceso para la preparacion de vectores geneticos para la expresion del factor de crecimiento nervioso en celulas eucariotas. | |
PL365473A1 (en) | Polyamine analogues as cytotoxic agents | |
PL346143A1 (en) | Tan-1057 derivatives | |
HUP0300219A2 (hu) | L-nukleozidokat, L-nukleotidokat és analógjaikat tartalmazó készítmények és alkalmazásuk | |
EP1036842A3 (en) | Use of cyanobacterial fructose-1,6-bisphosphatase to improve growth of plants | |
DE60100855D1 (de) | 1,8-naphthalimid imidazo[4,5,1-de]acridone mit antitumorwirkung | |
AU4884001A (en) | Novel collectins |